Hims & Hers Expands Health Access Through Subscription Revenue Model
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Hims & Hers Health ( NYSE:HIMS )
Investors with a lot of money to spend have taken a bearish stance on Hims & Hers Health ( NYSE:HIMS ) . We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't ...
The Secret to Finding the Next Amazon Is Hiding in Plain Sight
These innovators are disrupting massive industries with a customer-centric business strategy.
Hims & Hers Health, Inc. ( HIMS ) Laps the Stock Market: Here's Why
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $59.12, representing a +1.23% change from its previous close.
Not Nearly Enough People Are Talking About Chewy Stock
The company has multiple trends working in its favor.
1 No-Brainer Vanguard Index ETF to Buy Right Now for Less Than $1,000
The S&P 500 is still a smart all-around option, but there's good reason to start thinking about other index funds.
YieldMax's New ETF Turns Hims & Hers - Tidal Trust II YieldMax HIMS Option Income Strategy ETF ( ARCA:HIYY )
YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF ( NYSE: HIYY ) .
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
Hims & Hers Health, Inc. ( HIMS ) Is a Trending Stock: Facts to Know Before Betting on It
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
I'm Downgrading Hims & Hers Stock
The fast-growing company is taking investors on a roller-coaster ride.
Hims & Hers Health, Inc. ( HIMS ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $56, signifying a -2.95% move from its prior day's close.
Nvidia Just Got Another Tailwind -- Why Groq's $6.9 Billion Valuation Proves AI Chips Are Still Hot
Nvidia's unquestioned scale and ecosystem make it a clear winner.
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation
HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.
Oscar Health Set For HIMS-Style Moonshot? Shorts Could Burn As ACA Buzz Builds - Oscar Health ( NYSE:OSCR )
Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA ( Affordable Care Act ) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer is drawing Hims & Hers Health Inc HIMS style moonshot comparisons - and short sellers may be ...
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny On Weight-Loss ETFs - Hims & Hers Health ( NYSE:HIMS )
The FDA's crackdown has put Eli Lilly, Novo Nordisk and Hims & Hers under scrutiny, raising risks for ETFs tied to weight-loss treatments. Funds like THNR, HEAL and PTH offer diversification, but remain exposed to regulatory headwinds in the booming GLP-1 market. Want to trade this news?
How Is The Market Feeling About Hims & Hers Health? - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health's HIMS short interest as a percent of float has risen 6.29% since its last report. According to exchange reported data, there are now 74.64 million shares sold short, which is 40.92% of all regular shares that are available for trading.
Hims & Hers Health's Options Frenzy: What You Need to Know - Hims & Hers Health ( NYSE:HIMS )
Financial giants have made a conspicuous bearish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 13 unusual trades. Delving into the details, we found 38% of traders were bullish, while 53% showed bearish tendencies.
2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now
These dividend payers cranked up their payouts over the past decade, and they could do it again.
It's a Small World: 3 Stocks Leading the Sudden Rebound in Small Caps
A new market leader has snuck into town over the past month as Small Caps have pushed to the top of the leader board. Whether the trend lasts, or not, will depend a lot on what the Fed does, but one thing is certain.
What's Going On With Hims & Hers Health Stock On Tuesday? - Hims & Hers Health ( NYSE:HIMS )
FDA says Hims & Hers' semaglutide claims mislead consumers by implying they match approved drugs. The company must respond within 15 days or face potential legal actions like seizure and injunction. Want to trade this news? Get access to the 34-0 income strategy that loves volatility →
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.
Company News for Sep 16, 2025
Companies in The News Are: ...
Is Invesco Russell 2000 Dynamic Multifactor ETF ( OMFS ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Hims & Hers Health, Inc. ( HIMS ) Stock Sinks As Market Gains: Here's Why
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $54.03, signifying a -2.65% move from its prior day's close.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors Heavily Search Hims & Hers Health, Inc. ( HIMS ) : Here is What You Need to Know
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks - Hims & Hers Health ( NYSE:HIMS ) , Novo Nordisk ( NYSE:NVO )
Food and Drug Administration Commissioner Martin Makary stated on Friday that Hims & Hers Health Inc. HIMS broke federal law with its Super Bowl commercial promoting weight-loss drugs. Check out the current price of HIMS stock here.
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Hims & Hers Health, Inc. ( HIMS ) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $47.79, marking a -3.73% move from the previous day.
Should Invesco S&P MidCap 400 Pure Growth ETF ( RFG ) Be on Your Investing Radar?
Style Box ETF report for ...
Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem
HIMS expands its digital health footprint with global moves, top-tier partnerships and more than 1,500 providers.
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Cogent Biosciences ( NASDAQ:COGT ) , Alkermes ( NASDAQ:ALKS )
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wednesday. Shares of Macy's, Inc. M rose sharply during Wednesday's session after the company reported second-quarter results above estimates and raised its FY2025 guidance.
Here is What to Know Beyond Why Hims & Hers Health, Inc. ( HIMS ) is a Trending Stock
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HIMS' Personalized Wellness Platform Expands Preventive Care Access
Hims & Hers expands its personalized wellness platform, aiming to reshape preventive care through tech-driven, holistic solutions.
Will Chamath Palihapitiya's American Exceptionalism SPAC Succeed? Here's What History Says.
Chamath Palihapitiya just launched a new SPAC, called American Exceptionalism Acquisition Corp.
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?
Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Hims & Hers Health ( NYSE:HIMS )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers ( HIMS ) To Contact Him Directly To Discuss Their Options
Hims & Hers Scales Growth Through Subscriptions and Care Expansion
HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS - Hims & Hers Health ( NYSE:HIMS )
NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ( "Hims & Hers Health, Inc." or the "Company" ) HIMS of a class action securities lawsuit.
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Hims & Hers Health ( NYSE:HIMS ) , Oscar Health ( NYSE:OSCR ) , Rocket Companies ( NYSE:RKT )
Rocket, Oscar, and Hims boast sky-high short interest-making them prime tinder for a squeeze spark. With thin days-to-cover, shorts could flip fast from confident bets to panic-fueled fire drills. The market is reacting to Powell's speech. Learn how to time your next move. Details here →
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Hims & Hers Health ( NYSE:HIMS ) , Oscar Health ( NYSE:OSCR ) , Rocket Companies ( NYSE:RKT )
Rocket, Oscar, and Hims boast sky-high short interest-making them prime tinder for a squeeze spark. With thin days-to-cover, shorts could flip fast from confident bets to panic-fueled fire drills. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here →
DEADLINE ALERT for HIMS, IRBT, and CNC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Hims & Hers Health ( NYSE:HIMS ) , Centene ( NYSE:CNC )
LOS ANGELES, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
HIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action - HIMS - Hims & Hers Health ( NYSE:HIMS )
NEW YORK, Aug. 24, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. HIMS between April 29, 2025 and June 23, 2025, both dates inclusive ( the "Class Period" ) , of the important August 25, 2025 ...
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS - Hims & Hers Health ( NYSE:HIMS )
SAN DIEGO, Aug. 23, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Biohaven ( NYSE:BHVN ) , Centene ( NYSE:CNC )
BENSALEM, Pa., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. ( NYSE: HIMS ) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025 - Hims & Hers Health ( NYSE:HIMS )
PHILADELPHIA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ( "Hims & Hers" or the "Company" ) ( NYSE:HIMS ) .
Is Trending Stock Hims & Hers Health, Inc. ( HIMS ) a Buy Now?
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action - HIMS - ( HIMS )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. HIMS between April 29, 2025 and June 23, 2025, both dates inclusive ( the "Class Period" ) , of the important August 25, 2025 ...
